Unknown

Dataset Information

Rivaroxaban concentrations in acute stroke patients with different dosage forms.


ABSTRACT:

Background

The crushed-tablet rivaroxaban concentration has been previously reported to be lower than the non-crushed concentration. However, the rivaroxaban concentration of fine granules has not yet been investigated. The anticoagulation intensity of rivaroxaban with fine granules, tablets, and crushed tablets was compared in acute stroke patients to assess the efficacy of each form.

Methods and findings

Hospitalized patients over 75 years old with acute stroke who started taking rivaroxaban from April 2012 to September 2017 were included. Blood samples were drawn just before and 4 hours after taking rivaroxaban on a median of 5 days after treatment initiation for concentration measurements (C0h, C4h) based on an anti-factor Xa chromogenic assay. Of 114 patients (49 female

SUBMITTER: Wada S 

PROVIDER: S-EPMC6428291 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature